Trials / Completed
CompletedNCT00781040
Neutropenic Fever, Inflammatory Markers and Sepsis in Haematological Patients
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 273 (actual)
- Sponsor
- Kuopio University Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Not accepted
Summary
The aim of this study is to find out whether inflammation markers including cardiac markers have predictive value in evaluation of pathogenesis of sepsis in neutropenic haematological patients.
Detailed description
Adult AML and ASCT patients with neutropenic fever. Observation of possible progress to severe sepsis or septic shock. Blood sample collection on days 0-3 (from the beginning of neutropenic fever).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Severe sepsis vs. non-severe sepsis | To compare these two groups |
Timeline
- Start date
- 2006-12-01
- Primary completion
- 2019-01-01
- Completion
- 2019-01-01
- First posted
- 2008-10-28
- Last updated
- 2019-03-01
Locations
2 sites across 1 country: Finland
Source: ClinicalTrials.gov record NCT00781040. Inclusion in this directory is not an endorsement.